Neurovascular Tablets — a detailed guide to composition, benefits, and use.
Sustained-release combination of Propranolol and Flunarizine for effective prophylactic management of migraine and vascular headaches.
Flueye-P Tablets provide a synergistic combination of Propranolol Hydrochloride (Sustained Release) 40 mg and Flunarizine 10 mg for the prophylactic treatment of migraine and other vascular headaches. Propranolol, a non-selective beta-adrenergic blocker, reduces migraine frequency through central serotonergic modulation and cerebral vasoconstriction. Flunarizine, a calcium channel blocker, inhibits cortical spreading depression and stabilizes vascular smooth muscle. The sustained-release Propranolol formulation ensures consistent plasma levels throughout the day, while the complementary mechanisms of both agents provide superior prophylaxis compared to monotherapy.
| Composition | Propranolol HCl (SR) 40 mg + Flunarizine 10 mg |
| Dosage Form | Sustained-release film-coated tablet |
| Pack Size | 30 tablets per strip |
| Storage | Store below 30°C in a cool, dry place. Protect from moisture. |
| Shelf Life | 36 months from date of manufacture |
| Packaging | Strip of 10 tablets in printed carton |
| Dosage | 1 tablet once daily at bedtime, or as directed by physician |
Explore the complete product page for packaging, dosing, and enquiry options.
View Flueye-P Tablets Enquire NowDiscover more insights on eye health and ophthalmic care.